Transgender CEO speaks out on NC's HB2

Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2.
Up Next
Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2.

Martine’s message to North Carolina

May 16, 2016 07:13 PM